Lindsay Christensen
Nurse Practitioner · Ogden, UTNPI 1427701739
Payments from drug & device makers
Across 132 payments — averaging $22.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Sanofi$291
- GSK$215
- Grifols USA, LLC$179
- Takeda Pharmaceuticals U.S.A., Inc.$156
- Amgen$155
- plus $785 from 15 others
What the payments were for
- Food & beverage$2,87099%
- Education$341%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 45 | $1,123 |
| Sanofi | 13 | $291 |
| GSK | 13 | $215 |
| Grifols USA, LLC | 8 | $179 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $156 |
| Amgen | 7 | $155 |
| Regeneron Healthcare Solutions, Inc. | 6 | $135 |
| Novartis | 5 | $101 |
| Optinose US, Inc. | 5 | $97 |
| Biocryst US Sales Co., LLC | 3 | $81 |
| Kaleo, Inc. | 4 | $71 |
| CSL Behring | 3 | $60 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $50 |
| Pharming Healthcare, Inc. | 3 | $49 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Blueprint Medicines Corporation | 1 | $30 |
| Boston Scientific | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| AbbVie | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
| Lucid Diagnostics Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$115
How this compares
$2,904 in reported general payments places this provider in the 90th percentile of 979 nurse practitioner providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $24,402 |
| Spiriva RespimatTiotropium Bromide | 13 | $12,808 |
| Breo ElliptaFluticasone/Vilanterol | 18 | $11,607 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $8,720 |
| Advair HfaFluticasone Propion/Salmeterol | 14 | $8,071 |
| SymbicortBudesonide/Formoterol Fumarate | 16 | $7,534 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 37 | $5,367 |
| Epinephrine | 14 | $2,764 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 12 | $1,892 |
| Montelukast Sodium | 151 | $1,571 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 35 | $1,020 |
| Fluticasone Propionate | 26 | $549 |
| Azithromycin | 20 | $60 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $215 | $36,00942 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,123 | $16,25330 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 979 nurse practitioner providers in Utah.
Other nurse practitioner in Ogden
- Stacie EganOgden$170K
- Lynn LarsenOgden$16K
- Marinda PaskettOgden$13K
- Ryan WestbroekOgden$12K
- Aaron AdamsOgden$12K
- Austin BennionOgden$9K
- Raymond MillerOgden$6K
- Nancy ShinaOgden$4K
- Elizabeth ThompsonOgden$4K
- David GambleAmerican Fork$836K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.